C9-11289. Schedules of Controlled Substances: Proposed Placement of Zaleplon into Schedule IV
[Federal Register Volume 64, Number 90 (Tuesday, May 11, 1999)]
[Corrections]
[Page 25405]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C9-11289]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[DEA-182P]
21 CFR Part 1308
Schedules of Controlled Substances: Proposed Placement of
Zaleplon into Schedule IV
Correction
In proposed rule document 99-11289, beginning on page 24094 in the
issue of Wednesday May 5, 1999, make the following corrections:
1. On page 24094, in the third column, beginning in the eighth line
from the bottom, the sentence ``Zaleplon-related overdoes were also
noted during the clinical trials'' is removed.
2. On the same page, in the same column, in the fifth line from the
bottom, ``overdoes'' should read ``overdoses''.
[FR Doc. C9-11289 Filed 5-10-99; 8:45 am]
BILLING CODE 1505-01-D
Document Information
- Published:
- 05/11/1999
- Department:
- Drug Enforcement Administration
- Entry Type:
- Correction
- Document Number:
- C9-11289
- Pages:
- 25405-25405 (1 pages)
- Docket Numbers:
- DEA-182P
- PDF File:
-
c9-11289.pdf
- CFR: (1)
- 21 CFR 1308